These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36939341)

  • 21. Rift Valley Fever Virus Propagates in Human Villous Trophoblast Cell Lines and Induces Cytokine mRNA Responses Known to Provoke Miscarriage.
    Gwon YD; Nematollahi Mahani SA; Nagaev I; Mincheva-Nilsson L; Evander M
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface.
    McMillen CM; Megli C; Radisic R; Skvarca LB; Hoehl RM; Boyles DA; McGaughey JJ; Bird BH; McElroy AK; Hartman AL
    J Virol; 2024 Aug; 98(8):e0098324. PubMed ID: 39016561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis.
    Moser TS; Schieffer D; Cherry S
    PLoS Pathog; 2012; 8(4):e1002661. PubMed ID: 22532801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
    Barbeau DJ; Cartwright HN; Harmon JR; Spengler JR; Spiropoulou CF; Sidney J; Sette A; McElroy AK
    J Virol; 2021 Nov; 95(23):e0150621. PubMed ID: 34495703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    Brahms A; Mudhasani R; Pinkham C; Kota K; Nasar F; Zamani R; Bavari S; Kehn-Hall K
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium inhibits NF-κB nuclear translocation and modulate inflammation profiles in Rift valley fever virus-infected Raw 264.7 macrophages.
    Makola RT; Kgaladi J; More GK; Jansen van Vuren P; Paweska JT; Matsebatlela TM
    Virol J; 2021 Jun; 18(1):116. PubMed ID: 34088327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Host Factors for Rift Valley Fever Phlebovirus.
    Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CK1 and PP1 regulate Rift Valley fever virus genome replication through L protein phosphorylation.
    Bracci N; Baer A; Flor R; Petraccione K; Stocker T; Zhou W; Ammosova T; Dinglasan RR; Nekhai S; Kehn-Hall K
    Antiviral Res; 2024 Jun; 226():105895. PubMed ID: 38679165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
    Tercero B; Narayanan K; Terasaki K; Makino S
    J Virol; 2021 Jun; 95(14):e0042921. PubMed ID: 33952635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.
    Jansen van Vuren P; Tiemessen CT; Paweska JT
    PLoS One; 2011; 6(9):e25027. PubMed ID: 21949840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An LIR motif in the Rift Valley fever virus NSs protein is critical for the interaction with LC3 family members and inhibition of autophagy.
    Petraccione K; Ali MGH; Cyr N; Wahba HM; Stocker T; Akhrymuk M; Akhrymuk I; Panny L; Bracci N; Cafaro R; Sastre D; Silberfarb A; O'Maille P; Omichinski J; Kehn-Hall K
    PLoS Pathog; 2024 Mar; 20(3):e1012093. PubMed ID: 38512999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
    Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
    Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
    Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA Interference Restricts Rift Valley Fever Virus in Multiple Insect Systems.
    Dietrich I; Jansen S; Fall G; Lorenzen S; Rudolf M; Huber K; Heitmann A; Schicht S; Ndiaye EH; Watson M; Castelli I; Brennan B; Elliott RM; Diallo M; Sall AA; Failloux AB; Schnettler E; Kohl A; Becker SC
    mSphere; 2017; 2(3):. PubMed ID: 28497117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection
    Cartwright HN; Barbeau DJ; McElroy AK
    mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus-induced translational arrest through 4EBP1/2-dependent decay of 5'-TOP mRNAs restricts viral infection.
    Hopkins KC; Tartell MA; Herrmann C; Hackett BA; Taschuk F; Panda D; Menghani SV; Sabin LR; Cherry S
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):E2920-9. PubMed ID: 26038567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy.
    Alem F; Olanrewaju AA; Omole S; Hobbs HE; Ahsan N; Matulis G; Brantner CA; Zhou W; Petricoin EF; Liotta LA; Caputi M; Bavari S; Wu Y; Kashanchi F; Hakami RM
    Cell Biosci; 2021 Dec; 11(1):220. PubMed ID: 34953502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
    Dodd KA; Bird BH; Metcalfe MG; Nichol ST; Albariño CG
    J Virol; 2012 Apr; 86(8):4204-12. PubMed ID: 22345465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.
    Schwarz MM; Connors KA; Davoli KA; McMillen CM; Albe JR; Hoehl RM; Demers MJ; Ganaie SS; Price DA; Leung DW; Amarasinghe GK; McElroy AK; Reed DS; Hartman AL
    J Virol; 2022 Oct; 96(20):e0111222. PubMed ID: 36194021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.
    Lorenzo G; Rodríguez-Pulido M; López-Gil E; Sobrino F; Borrego B; Sáiz M; Brun A
    Antiviral Res; 2014 Sep; 109():64-7. PubMed ID: 24973761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.